A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents
Ksana Health · with National Institute of Mental Health (NIMH), University of Pittsburgh Medical Center · NCT07348666
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 13–24 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 2
- Study start
- June 18, 2026
- Record last updated
- August 12, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to increase engagement with effective interventions such as suicide safety planning. The BRITE suicide safety planning app was developed on evidence-based principles and has undergone rigorous formative development and effectiveness evaluations. However, to optimize its functionality, commercial viability, and scale its implementation, issues related to user engagement needed to be addressed. This 3 month Pragmatic Randomized Trial will evaluate the impact of the ViraSafe app-an enhanced version of the BRITE suicide safety planning app-on improving engagement with coping skills and safety planning among suicidal adolescents by comparing its intervention components to those of the original BRITE app.
Being studied: ViraSafe: Treatment pushes; BRITE
Conditions: Suicide; Mental Health Disorder; Anhedonia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Youth (minors):
- 13-17 years old
- Suicide attempt in the last year and ideation in the past month
- English fluency and literacy
- Parent or legal guardian willing and able to legally provide informed consent
- Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan
Youth (adults)
- 18-24 years old
- Recent suicide attempt or ideation with a plan
- English fluency and literacy
- Receiving care at one of the study clinical settings with trained providers to onboard ViraSafe or BRITE safety plan.
Exclusion Criteria
Youth (minors):
- Unable to read/understand English
- Current manic or psychotic episode
- Development disability precluding comprehension of study procedures
- No routine access to a mobile phone, assessed by EHR review and during phone screen
- No eligible parent or legal guardian to provide informed consent
Youth (adults):
- Unable to read/understand English
- Current manic or psychotic episode
- Development disability precluding comprehension of study procedures
- No routine access to a mobile phone, assessed by EHR review and during phone screen
Recruiting US locations
STAR Center, Western Psychiatric Institute & Clinic
Pittsburgh, PA 15213
Site contact: David Brent Co-Director, MD · 412-246-5619 · Brentda@upmc.edu
University of Pittsburgh
Pittsburgh, PA 15213
Site contact: Stephanie Stepp, Ph.D. · 412-383-5051 · steppsd@upmc.edu
Study contacts (from the official record)
- Stephanie Stepp, PhD · 412-383-5051 · steppsd@upmc.edu
Similar studies in Pennsylvania
All mental health studies in Pennsylvania →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Philadelphia, PA + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
NeurOptics Inc
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 3–17
- RecruitingPhase 3
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Definium Therapeutics US, Inc.
- Location
- Philadelphia, PA + 22 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Philadelphia, PA + 19 other US sites
- Eligibility basics
- Ages 18+